Home » Authors » Mark Lawson

Articles by Mark Lawson

BresaGen Merging Operations Of Stem Cell Unit With CyThera

Dec. 2, 2003

Peptech Settles License Dispute Concerning Abbott Labs' Humira

Nov. 26, 2003

Peptech Settles License Dispute Concerning Abbott Labs' Humira

Nov. 26, 2003

Financing Jump In Third Quarter; Cryptome, Pharmaxis Price IPOs

Oct. 15, 2003

Financing Jump In Third Quarter; Cryptome, Pharmaxis Price IPOs

Oct. 15, 2003

Singapore Making Biotech Waves With Vast New Biopolis Facility

Sep. 3, 2003

Singapore Making Biotech Waves With Vast New Biopolis Facility

Sep. 3, 2003

BresaGen Moving Operations To U.S. For Better Biotech Climate

Aug. 20, 2003

BresaGen Moving Operations To U.S. For Better Biotech Climate

Aug. 20, 2003

Australian Firm Defends Fees For Access To Noncoding DNA

July 16, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...